Opportunity ?As I write this , AGN is down 2 cents on low volume of 290k shares. It would appear that some small investors were expecting more from Chris yesterday. Maybe there should have been,
I tend to believe that clinicals like this are not easy and straight forward. We have certainly seen this with the big companies doing vaccine clinicals!
We are a small company doing small clinicals, but we have a " safe " drug that has been shown to have much potential.
We don't need the clinicals to show that Ifenprodal can cure covid 19. We just need to see that it did indeed improve the outcome for these patients. We may be able to be part of a " cocktail " treatment or even a go it alone treatment ( pie in the sky, SP through the roof result )
Either way , we will be selling alot of product to help people survive.
I for one continue to roll the dice and buy more at this price.
Next stop will be announcement of 100% enrollment which will most likely result in a small bump.
Anything positive after that and we are happy campers !
JMHO
Rico